Cogent Biosciences COGT
NASDAQ COGT
$31.18 -0.25 (-0.80%)
As of: Oct 22, 2026 · 11:27 AM EDT

Cogent Biosciences (COGT) Other Operating Expenses (2020)

Updated

Cogent Biosciences (COGT) posted Other Operating Expenses of $46.91 million for FY2020.

Analysis

Cogent Biosciences (COGT) Other Operating Expenses (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,175.39 Bn 1,143.98 Bn 19.71 Bn
2 Johnson & Johnson 639.10 Bn 557.63 Bn 17.26 Bn
3 AbbVie 502.70 Bn 475.81 Bn 12.70 Bn
4 Merck 376.68 Bn 331.05 Bn 12.21 Bn
5 Novartis Ag 304.33 Bn 268.32 Bn 11.24 Bn
6 Astrazeneca 267.75 Bn 241.43 Bn 12.86 Bn
7 Amgen 242.34 Bn 197.73 Bn 7.24 Bn
8 Gilead Sciences 193.67 Bn 167.87 Bn 6.22 Bn
9 Pfizer 172.62 Bn 119.27 Bn 10.94 Bn
10 Cogent Biosciences 5.33 Bn 2.38 Bn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 46.91 Mn
API Access

Cogent Biosciences Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=COGT&period=max&api_key=YOUR_API_KEY